Paclitaxel And Cisplatin Combined With Anlotinib As First Line Regimen For Advanced Esophageal Squamous Cell Carcinoma (Escc): A Single-Arm, Multicentre Open-Label Phase Ii Clinical Trial
Annals of Oncology（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要